Clinical Trial Detail

NCT ID NCT03746080
Title Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Lawrence Recht
Indications

malignant glioma

Therapies

Plerixafor + Temozolomide

Age Groups: adult senior

No variant requirements are available.